 It is caused by the presence of antibodies against anionic phospholipids and β2-glycoprotein I (β2GPI).The anti-β2GPI antibodies are most prevalent in causing the symptoms of the disease.When bound by an antibody, β2GPI begins to interact with monocytes, endothelial cells, and platelets.